SCHEMBL19294706

SCHEMBL19294706

C[C@@H]1CN(C2CC2)C[C@H]1NC(=O)c1cccc(N2CCCC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
L3MBTL3 Q96JM7 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
RAB9A P51151 5/20 0.48
CCR2 P41597 2/20 0.43
KCNH2 Q12809 1/20 0.43
TAS1R3 Q7RTX0 2/20 0.42
TAS1R1 Q7RTX1 2/20 0.42
TAS1R2 Q8TE23 2/20 0.42
NPC1 O15118 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
MAPT P10636 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19282373 1.00 MEN1 (0.50) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19282376 1.00 MEN1 (0.50) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19282511 1.00 MEN1 (0.50) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19294704 1.00 MEN1 (0.50) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19282490 0.86 SMYD3 (0.52) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19282379 0.86 SMYD3 (0.52) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19282382 0.86 SMYD3 (0.52) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19294696 0.86 SMYD3 (0.52) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL21703567 0.81 KDM4E (0.53) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL13702428 0.72 MEN1 (0.66) MEN1KMT2AALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048195-A1 SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS Epizyme, Inc. 2020-02-13 US disclosed
US-20170247326-A1 Substituted Pyrrolidine Carboxamide Compounds Epizyme, Inc. (US) 2017-08-31 US disclosed
US-20170247326-A1 Substituted Pyrrolidine Carboxamide Compounds Epizyme, Inc. (US) 2017-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247326-A1 Substituted Pyrrolidine Carboxamide Compounds SMYD3, SMYD2, SMURF2 MEN1 2993/4885KMT2A 616/4885ALDH1A1 2292/4885
US-20200048195-A1 SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS SMYD3, SMYD2, SMURF2 MEN1 2993/4885KMT2A 616/4885ALDH1A1 2292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.